Recombinant Anti-SARS-CoV-2 RBD Biparatopic Antibody, Symmetric IgG-sdAb

CAT#: VS-0525-YC11

This is a neutralizing biparatopic antibody against SARS-CoV-2, binding with high affinity to two non-overlapping epitopes on the Receptor-Binding Domain (RBD). It effectively blocks RBD attachment to human Angiotensin-Converting Enzyme 2 (ACE2) and potently neutralizes SARS-CoV-2, showing IC50 values of 30 pM for Omicron (BA.1) and 50 pM for Delta in pseudovirus assays. The antibody could be effective against all current variants of concern (VOCs) of SARS-CoV-2.

Specifications

  • Host Animal 1
  • Human
  • Host Animal 2
  • Human
  • Specificity
  • SARS-CoV-2 RBD
  • Species Reactivity
  • SARS-CoV-2
  • Type
  • Symmetric IgG-sdAb
  • Valency
  • 2 + 2
  • Purity
  • >90%
  • Purification
  • Affinity purified
  • Applications
  • ELISA, Neut, SPR
  • Concentration
  • Lot specific
  • Buffer
  • PBS, pH 7.4
  • Preservative
  • No preservatives
  • Storage
  • Store at 4°C for short term. Aliquot and store at -20°C for long term. Avoid freeze-thaw cycles.
  • Long Name
  • SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD)

Target

  • Introduction
  • The 140 kDa SARS-CoV-2 S protein is organized into two major subunits (S1 and S2) connected by a furin-cleavage site. The S1 subunit contains the receptor-binding domain (RBD; aa 319-541), a 25 kDa domain that is directly involved in the interaction with the Angiotensin-converting enzyme 2 (ACE2). The RBD contains nine cysteines, including eight that form disulfide-bridges involved in the RBD fold. In addition, the domain displays two N-glycosylation sites (Asn331 and Asn343) known to participate in folding, stability and function. Mutations occurring within this domain are constantly monitored to predict the emergence of novel variants that could be naturally selected and quickly spread, such as the recent isolated alpha (B.1.1.7), beta (B.1.351), gamma (P.1) and delta (B.1.617.2) variants of concern.
  • Alternative Names
  • SARS-CoV S protein; RBD Domain
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for VS-0525-YC11. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "SARS-CoV-2 RBD"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
VS-0125-FY108 Human Anti-SARS-CoV-2 RBD (clone II62) scFv-Fc Chimera Inhib Human IgG1, scFv-Fc
VS-0325-FY45 Human Anti-SARS-CoV-2 RBD (clone S15) scFv-Fc Chimera Neut Human IgG1, scFv-Fc
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare